About the Prostate Cancer Journal Club for Patients
The Prostate Cancer Journal Club for Patients (PCJCP) is hosted by UroToday, the Prostate Cancer Foundation, University of California San Francisco, and the UCSF Patient Services Committee.
The PCJCP presents recent, game-changing medical papers relevant to prostate cancer patients with the goal of avoiding complex medical jargon and focusing on direct impact on patients’ treatments.
The purpose is to educate patients to help them make better decisions about their prostate cancer care in collaboration with their doctors.
You can find recordings of our previous webinars here:
|
Webinar Topic |
Webinar recording |
Patient Q&A Recording |
|
How microscopic features in prostate tumor tissue can predict with high accuracy which patients are likely to progress to metastasis, independent of Gleason grading. |
||
|
A 15-year randomized trial comparing surgery, radiation, and active surveillance |
||
|
Comparing the effectiveness and side effects of three treatment options for men with high-risk disease and rapidly rising PSA after primary therapy: (1) ADT monotherapy, (2) Enzalutamide monotherapy, (3) Combined Enzalutamide and ADT |